20 articles
Real-world Australian study shows promising results for teduglutide in reducing dependency on IV nutrition in short bowel syndrome patients.
Major review reveals how specific gut microbes influence insulin resistance and offers new targets for diabetes prevention.
A stem cell intestine model screened 3,500 compounds and flagged glycyrrhizin from black licorice as a top anti-inflammatory candidate for IBD.
New research reveals how prebiotic inulin reprograms intestinal cells by creating low-oxygen conditions that activate growth signals.
Research finds the absorption enhancer in oral semaglutide tablets affects gut bacteria and inflammation markers beyond its intended role.
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
A leading GLP-1 researcher reveals what Ozempic and Mounjaro really treat, their benefits beyond weight loss, and how to use them safely.
Small pilot study tests whether resistant starch from potatoes can safely modify gut bacteria in cancer patients receiving dual checkpoint inhibitors.
Clinical trial tests safety of combined prebiotic-probiotic supplement in 32 healthy participants over 5 months.
Researchers identify a gut-microbe-driven pathway linking IBS-D and insulin resistance, with oleoylethanolamide as a key therapeutic molecule.
Scientists develop gut-targeted compound that protects liver and boosts nutrient absorption after small bowel surgery, offering hope where no treatments exist.
GLP-1 drugs shrink appetite but risk muscle loss and nutrient gaps. Here's what to eat before, during, and after treatment.
A common oat fiber supercharges anti-PD-1 checkpoint therapy by expanding a key gut microbe that produces immune-activating metabolites.
Comprehensive review reveals how bacterial and fungal overgrowth in the small intestine triggers systemic inflammation and metabolic dysfunction.
New research shows how beneficial gut bacteria process plant sugars, revealing pathways that could optimize digestive health.
New research shows this beneficial gut microbe blocks obesity and improves metabolism through nicotinamide riboside production.
First study to quantify food additives in Crohn's patients reveals higher sweetener levels and altered emulsifier metabolism tied to disease severity.
A mouse study shows CD38 inhibition protects colon architecture during 5-FU chemotherapy by preventing NAD+ depletion.
New research reveals that inulin fiber can suppress immune defenses against parasites through direct effects on gut immunity.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
